Stocksigma LogoStocksigma Logo

Alembic Pharma Receives USFDA EIR for Vadodara Bioequivalence Facility

Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR)

Alembic Pharma Receives USFDA EIR for Vadodara Bioequivalence Facility

Alembic Pharmaceuticals Ltd 路 Others (Uncategorized) 路 16 Sept 2026, 11:37 pm

Alembic Pharma Receives USFDA EIR for Vadodara Bioequivalence Facility Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR), successfully closing the inspection for its Bioequivalence Facility located at Vadodara, Gujarat. The regulatory audit was conducted between 3rd Mar'25 and 7th Mar'25. The receipt of the EIR confirms regulatory compliance and clears the facility of pending inspectional concerns.

Original exchange filing (PDF)

More announcements from Alembic Pharmaceuticals Ltd

All Alembic Pharmaceuticals Ltd announcements